Products & Services · Total revenues

Tyvaso DPI — Total revenues

United Therapeutics Tyvaso DPI — Total revenues decreased by 2.5% to $330.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.2%, from $302.50M to $330.30M. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2021
Last reportedQ1 2026
Rolls up toTotal Revenue

How to read this metric

An increase indicates growing market demand or successful commercial penetration, while a decrease may signal market saturation, increased competition, or loss of patent exclusivity.

Detailed definition

Represents the total gross revenue generated from the sale of a specific pharmaceutical product or therapeutic line with...

Peer comparison

Standard revenue reporting for specific drug franchises or product lines across pharmaceutical peers.

Metric ID: uthr_segment_tyvaso_dpi_total_revenues

Historical Data

17 periods
 Q2 '21Q3 '21Q4 '21Q3 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$0.00$0.00$63.10M$118.70M$193.60M$205.10M$213.70M$227.50M$258.30M$274.60M$273.20M$302.50M$315.20M$336.20M$338.60M$330.30M
QoQ Change+88.1%+63.1%+5.9%+4.2%+6.5%+13.5%+6.3%-0.5%+10.7%+4.2%+6.7%+0.7%-2.5%
YoY Change+225.0%+91.7%+33.4%+33.9%+27.8%+33.0%+22.0%+22.4%+23.9%+9.2%
Range$0.00$338.60M
Avg YoY Growth+52.2%
Median YoY Growth+30.4%

Frequently Asked Questions

What is United Therapeutics's tyvaso dpi — total revenues?
United Therapeutics (UTHR) reported tyvaso dpi — total revenues of $330.30M in Q1 2026.
How has United Therapeutics's tyvaso dpi — total revenues changed year-over-year?
United Therapeutics's tyvaso dpi — total revenues increased by 9.2% year-over-year, from $302.50M to $330.30M.
What does tyvaso dpi — total revenues mean?
The total sales revenue generated by a specific product line.